Corporeal distribution and placental transfer of selenium after a single injection of sodium selenite (SS) were investigated over a period of 24 h with regard to the gestational stages of mice and the injection routes of SS. On day 16 of gestation, feto-placental accumulation of selenium was remarkably increased compared with that on day 12 following subcutaneous (sc) injection of SS.
INTRODUCTION
The toxicity of sodium selenite (SS) in pregnant mice has been recently demonstrated by Yonemoto et al.1-2) They reported a dose-effect relationship caused by subcutaneous (sc) injection of SS in the late gestational period, i.e., from high to low doses, maternal death, abortion, fetal loss, or fetal growth retardation were observed, and these toxic manifestations differed according to the gestational stage of the mouse, the injection route of SS used, or could be modified with glutathione (GSH), vitamin E or methylmercury. A single sc injection of SS on day 16 of gestation caused maternal death and abortion at a lower dose level than that on day 12,1) An intravenous (iv) injection on day 12 * Present address : Department of Public Health , School of Pharmaceutical Sciences, Kitasato University, 5-9-1 Shirokane, Minato-ku, Tokyo 108, Japan ** To whom correspondence should be sent at the first address .
caused not abortion but maternal death at a lower dose level than sc injection.1,2) Pretreatment with GSH1) and coadministration of methylmercury3) enhanced SSinduced maternal death and abortion at a lower dose level of SS than a single injection of SS alone. Pretreatment with vitamin E prevented the abortion-inducing effect of SS but did not block the fetocidal effect or fetal growth retardation.'
The mechanism of induction of death or abortion by SS has not been clarified. In the experiments conducted by Yonemoto et al.1), death and abortion induced by SS injection occurred within 1 or 2 days after the injection. Heinrich and Kelsey8) have reported that selenite metabolism is very rapid, and that its levels in certain organs and tissues change greatly with time after its injection into mice. This must be taken into consideration in studying the toxicokinetics of SS. In this paper, corporeal distribution and placental transfer of selenium over a 24-h time course following a single injection of SS was investigated in pregnant mice with regard to the effect of the two stages of gestation or of the two routes of injection used. dose and ratios of selenium concentration in the fetus to that in the placenta were subjected to angular transformation for statistical analysis. The effects of the gestational age factor, the time course factor and their interaction on variations in the data were analyzed by two-way variance analysis (ANOVA), which was also used to study the effects of the injection route factor, the time course factor and their interaction.
RESULTS
No abortion, maternal or fetal death was observed during the 24 h following treatment in all groups. In the following results, weights or selenium contents of fetuses or placentas were expressed as those of whole fetuses or placentas, since there was no significant difference in litter sizes among the treatment groups. Differences by gestational age: Table 2 summarizes the weights of organs taken Untreated mice, 6 on day 12 and 5 on day 16, were sacrificed and weight ratios of the organs were calculated. Asterisks (*, **, and ***) show signifiicant differences in means between the two gestational age groups of p<0.05, p<0.01 and p<0.001, respectively, by t-test. AND day 16 group, selenium concentrations in the liver, kidneys, lungs, placentas, and fetuses were significantly higher than those in the day 12 group (ANOVA, gestational age effect, p < 0.01, p < 0.05, p < 0.001, p < 0.05, and p > 0.001, respectively).
Elevated fetal concentrations in the day 16 group compared with those in the day 12 group were noted in all the time course groups (t-test).
Variation in selenium concentrations during the time course period was observed in most of the organs and tissues except for the uterus and fetuses. The highest concentrations appeared at 1 h in the liver, kidneys, spleen, and lungs (ANOVA, time effect, p < 0.001, p < 0.001, p < 0.01, and p < 0.001, respectively), and at 4 h in the heart, brain, and placentas (ANOVA, time effect, p < 0.001, p < 0.001, and p < 0.01, respectively) in both gestational age groups. In the fetus, concentrations stayed almost constant during the time course of observation.
Different kinetics were observed in selenium concentrations between the two in erythrocytes appeared at 4 h, while this was observed at 1 h in the day 12 group (ANOVA, interaction, p < 0.01).
Hepatic concentration at 4 h decreased by 40% from that at 1 h in the day 12 group (t-test, p < 0.01), whereas no decrease was observed in the day 16 group (ANOVA, interaction, p < 0.01). Table 4 shows the proportion of the amount of selenium found in the organs and tissues to the administered doses (percentage of dose). Percentage of dose in the liver, kidneys, heart, or lungs was independent of gestational age, but that in the spleen or brain was decreased on day 16 (ANOVA, gestational age effect, p < 0.01 for both). Percentages of dose in the placentas and fetuses on day 16 were about two-fold and ten-fold, respectively, greater than those on day 12 (ANOVA, gestational age effect, p < 0.001 for both).
Patterns in the variation of the percentage of dose during the time course were similar to those observed for the concentration for many organs and tissues except the spleen, placentas and fetuses. These three showed weight changes after the injection. In the spleen, decrease in the percentage of dose following the time course was accelerated by weight decrease (ANOVA, time effect, p < 0.001). In the placenta, weight decrease cancelled the concentration incrase at 4 h after injection. Weight gain of the fetus after injection increased the percentage of dose (ANOVA, time effect, p < 0.001) in spite of the fact that the concentration was constant during the time course.
The ratio of selenium concentration in the fetus to that in the placenta was significantly higher in the day 16 group than in the day 12 group (see Fig. 2 ; ANOVA, gestational age effect, p < 0.001).
Differences by injection route: Body weights and organ weights were identical when sc and iv injection groups were compared, but smaller splenic weights were seen in the sc group (data not shown). Table 5 shows tissue selenium concentrations.
In the iv group, significantly Table 5 . Comparison of tissue selenium concentrations between the two routes of injection used during the time course after the injection higher concentrations in the kidneys, spleen, heart, lungs, brain, and erythrocytes were found compared with the values in the sc group (ANOVA, injection route effect, p < 0.01, p < 0.01, p < 0.001, p < 0.05, p < 0.001, and p < 0.001, respectively). In the placentas and fetuses, no difference in selenium accumulation between the two routes of injection was detected (ANOVA, route effect, p > 0.05 for both). Variations in concentration during the time course were almost similar between the sc and iv injection groups in all of the organs (ANOVA, interaction, p > 0.05 for all).
DISCUSSION
In the present investigation, a single sc injection of SS caused noticeable differences in distribution and placental transfer of selenium between the two stages of gestation which were studied. Selenium concentrations were higher in the day 16 group in the liver, kidneys, and lungs than in the day 12 group,but there was no difference in the precentage of dose in these organs between the two gestational age groups. Since the dose was proportional to the body weight at the time of injection, this might have been due to the decreased weight ratios of those organs to the body weight on day 16 compared with those on day 12. Intravenous injection of selenite caused increased selenium concentrations in most of the maternal organs and tissues, but not in the fetus and placenta. This may be the reason why abortion was not observed with iv injection of selenite2). Before selenium accumulation in the feto-placental area reached the critical point of inducing abortion. maternal death might have occurred.
In this study, critical organs and concentrations of selenium which may correspond to the toxic manifestations of SS, such as abortion or maternal death, were examined. The chemical form of selenium administered or the biochemical changes induced by SS injection in the critical organs and tissues is the next problem which remains to be studied, for clarifying the mechanism of death or abortion induced by SS injection. 
